In one study, clonal expansions of LGL cells expressing CD3, CD56, and γδ TCRs were observed in 3.6% (19/529) of RA patients and were found to positively correlate with exposure time to TNF blocking agents (38). The gene discussed is TNF; the disease is rheumatoid arthritis.